- Home
- SNGX vs MRM Comparison
SNGX vs MRM Comparison
Compare SNGX & MRM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SNGX
- MRM
- Stock Information
- Founded
- SNGX 1987
- MRM 2000
- Country
- SNGX United States
- MRM Japan
- Employees
- SNGX N/A
- MRM N/A
- Industry
- SNGX Biotechnology: Pharmaceutical Preparations
- MRM Other Consumer Services
- Sector
- SNGX Health Care
- MRM Consumer Discretionary
- Exchange
- SNGX Nasdaq
- MRM Nasdaq
- Market Cap
- SNGX 6.5M
- MRM 5.9M
- IPO Year
- SNGX 1987
- MRM 2020
- Fundamental
- Price
- SNGX $1.25
- MRM $1.40
- Analyst Decision
- SNGX
- MRM
- Analyst Count
- SNGX 0
- MRM 0
- Target Price
- SNGX N/A
- MRM N/A
- AVG Volume (30 Days)
- SNGX 2.7M
- MRM 21.3K
- Earning Date
- SNGX 08-08-2025
- MRM 05-20-2025
- Dividend Yield
- SNGX N/A
- MRM N/A
- EPS Growth
- SNGX N/A
- MRM 27.65
- EPS
- SNGX N/A
- MRM 0.18
- Revenue
- SNGX $2,342.00
- MRM $52,786,758.00
- Revenue This Year
- SNGX N/A
- MRM N/A
- Revenue Next Year
- SNGX N/A
- MRM N/A
- P/E Ratio
- SNGX N/A
- MRM $7.66
- Revenue Growth
- SNGX N/A
- MRM 21.55
- 52 Week Low
- SNGX $1.09
- MRM $0.34
- 52 Week High
- SNGX $14.83
- MRM $8.39
- Technical
- Relative Strength Index (RSI)
- SNGX 32.97
- MRM 50.02
- Support Level
- SNGX $1.09
- MRM $1.33
- Resistance Level
- SNGX $1.88
- MRM $1.50
- Average True Range (ATR)
- SNGX 0.13
- MRM 0.09
- MACD
- SNGX -0.02
- MRM -0.02
- Stochastic Oscillator
- SNGX 20.25
- MRM 38.10
About SNGX Soligenix Inc.
Soligenix Inc is a late-stage biopharmaceutical company based in the United States. It focuses on developing and commercializing products to treat rare diseases where there is an unmet medical need. The company operates through two business segments namely Specialized BioTherapeutics and Public Health Solutions. It generates maximum revenue from Public Health Solutions with active development programs for RiVax, its ricin toxin vaccine candidate, SGX943, its therapeutic candidate for antibiotic resistant and emerging infectious disease, and its research programs to identify and develop novel vaccine candidates targeting viral infection including Ebola, Marburg and SARS-CoV-2 (the cause of COVID-19).
About MRM MEDIROM Healthcare Technologies Inc.
MEDIROM Healthcare Technologies Inc provides health services. The company is a franchiser and operator of healthcare salons and operates in segments namely Relaxation Salon, Digital Preventative Healthcare, and Luxury Beauty Segment. The company generates a majority of its revenue from the Relaxation Salon business segment. Geographically, the company generates a maximum share of its revenue from Japan.